Unity Software - Unity Software, founded in 2004 and based in San Francisco, provides a software platform for creating and expanding video games across various platforms, including mobile, PC, console, and XR [3] - The company has a market capitalization of approximately $8 billion and has seen its stock decline by 58% year to date [8] - Unity's revenue outlook for Q1 2026 is projected to be between $480 million and $490 million, which is below the Wall Street expectation of $494 million [9] - In Q4 2025, Unity reported a revenue of $503 million, a 10% year-over-year increase, and exceeded forecasts by $10.18 million [10] - Analyst Martin Yang from Oppenheimer maintains a positive outlook on Unity, suggesting that the recent stock sell-off is misplaced and that the company will see accelerating revenue growth and margin expansion in 2026 [11] - The consensus rating for Unity is Moderate Buy, with 15 Buy, 4 Hold, and 1 Sell ratings, and an average target price of $37.53 indicating a potential upside of 102% [12] Thomson Reuters - Thomson Reuters, formed in 2008, is a global information and content conglomerate with a market cap of nearly $37 billion, providing services to professionals in legal, tax, accounting, and compliance fields [13] - The company reported $2 billion in revenue for Q4 2025, a nearly 5% year-over-year increase, and exceeded estimates by $9.5 million [16] - Analyst Drew McReynolds from RBC views the current stock price as an opportunity for investors, projecting a 12-month price target of $126, which implies a 47% gain [17] - The consensus rating for Thomson Reuters is Strong Buy, with 10 Buy and 3 Hold ratings, and an average target price of $134.59 indicating a potential gain of 57% [17] Doximity - Doximity is a health-tech platform designed for medical professionals, connecting approximately 80% of US doctors and 50% of nurse practitioners [20] - The company reported $185.1 million in revenue for fiscal Q3 2026, a 10% year-over-year increase, and exceeded forecasts by $3.5 million [23] - Doximity's shares have declined by 42.5% this year, primarily due to low guidance for fiscal Q4 2026, projecting revenue between $143 million and $144 million compared to a consensus of $150.53 million [22] - Analyst Richard Close from Canaccord believes the recent sell-off is an overreaction and maintains a Buy rating with a price target of $34, predicting a 34% upside [24] - The consensus rating for Doximity is Strong Buy, with 14 Buy and 4 Hold ratings, and an average target price of $41.47 indicating a potential upside of 63% [24]